Single arm intervention study of the efficacy of the App for improving the lifestyle behavior in patients with Type 2 DM - Single arm intervention study of the efficacy of the App for improving the lifestyle behavior in patients with Type 2 DM

Mitsubishi Tanabe Pharma Corporation0 sites58 target enrollmentStarted: April 5, 2021Last updated: October 17, 2023

Conditions

Trial Snapshot

No summary available.

•1) A female subject who wishes to become pregnant, is pregnant, or is breastfeeding 2) Patients diagnosed with type 1 diabetes mellitus 3) Patients with a diagnosis of secondary diabetes mellitus 4) Patients with physician-determined advanced complications 5) Patients scheduled for hospitalization or surgery during this study 6) Patients with diseases other than diabetes mellitus who are instructed to restrict exercise 7) Patients who have participated in a clinical study or a post-marketing clinical study of another prescription drug or a medical device within 3 months, who are now participating in such a study, or who plan to participate in such a study during this study 8) Patients who have used a mobile application running on a smartphone terminal for the purpose of managing or assisting diabetes mellitus within the past 3 months 9) Medical institution staff or close relatives involved in this study 10) Other patients judged by the investigator to be inappropriate for inclusion in this study

Sponsor